DAR ZAVAIN received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/23/2025ACC: 0001601830-25-000109
Director
Since Apr 2021
+66.05K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
66.05K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+22.02K
Price / share
—
Trade value
—
% of position
19.9%
6/18/2025
110.88K→132.89K
Total
Net shares
+22.02K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/18/2025 | A · Award | +22.02K | — | — | 19.9% | 110.88K | 132.89K |
| Total | +22.02K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
44.03K shares
Shares
+44.03K
Strike price
5.11
Held after
44.03K
Exercisable
—
6/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock44.03K shares | 6/18/2025 | A · Award | +44.03K | 5.11 | — | 44.03K |